5-bromo-N-(2,2-dimethylpropyl)-3-nitro-2-pyridinamine, 95.0%, 5g

1-(4-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (Ibrutinib Impurity), 97%, 50mg

6,7-Dimethoxyquinazoline-2,4-dione>98.0%(HPLC)(T)5g

10,10-Dimethylanthracen-9(10H)-one>98.0%(GC)5g

2,4-dimethyl-8-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-7-one, 95%, 5mg

Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid, 95.0%, 250mg

2,5-DIBROMO-4-FLUOROBENZALDEHYDE, 95%, 1g

3-Bromo-2-fluorobenzoic Acid>98.0%(GC)(T)5g

tert-butyl N-[(1R,3S)-3-aminocyclopentyl]carbamate;hydrochloride, 97, 1g

Heating bath liquid ROTITHERM® H 250, 10 l

Cyclopentene>98.0%(GC)100mL

tert-Butyl (1-cyclopropyl-1H-imidazol-4-yl)carbamate, 95.0%, 250mg

2-Chloroquinoxalin-6-amine, 97%, 250mg